Clinical evaluation and analysis of heart valve substitutes

Journal of Heart Valve Disease

Volumn 7, Issue 2, 1998, Pages 163-169

  Grunkemeier, Gary L ^a,b   Anderson Jr , William N ^a  

^a EARLE A CHILES RESEARCH INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ENDOCARDITIS; FOOD AND DRUG ADMINISTRATION; HEART VALVE PROSTHESIS; HEMODYNAMICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; THROMBOSIS;

BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS; CLINICAL TRIALS; CONFIDENCE INTERVALS; EQUIPMENT SAFETY; EVALUATION STUDIES; GUIDELINES; HEART VALVE PROSTHESIS; HUMANS; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS; REFERENCE STANDARDS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0031961463     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Grunkemeier GL. Will randomized trials detect random valve failure? Reflections on a recent FDA workshop. J Heart Valve Dis 1993;2:424-429
2. Gersh BJ, Fisher LD, Schaff HV, et al. Issues concerning the clinical evaluation of new prosthetic valves. J Thorac Cardiovasc Surg 1986;91:460-466
3. Grunkemeier GL, Johnson DM, Naftel DC. Sample size requirements for evaluating heart valves with constant risk events. J Heart Valve Dis 1994;3:53-58
4. Clark RE, Edmunds LH, Jr., Cohn LH, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. J Thorac Cardiovasc Surg 1988;96:351-353
5. Clark RE, Edmunds LH, Jr., Cohn LH, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1988;46:293-295
6. Clark RE, Edmunds LH, Jr., Cohn LH, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Eur J Cardiothorac Surg 1988;2:293-295
7. Grunkemeier GL, Starr A, Rahimtoola SH. Prosthetic heart valve performance: Long-term follow-up. Curr Probl Cardiol 1992;17:329-406
8. Draft Replacement Heart Valve Guidance, Version 4.1. Division of Cardiovascular, Respiratory, and Neurological Devices, Center for Devices and Radiological Health, Food and Drug Administration. October 14, 1994
9. Edmunds LH, Jr., Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1996;62:932-935
10. Edmunds LH, Jr., Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. J Thorac Cardiovasc Surg 1996;112:708-711
11. Edmunds LH, Jr., Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Eur J Cardiothorac Surg 1996;10:812-816
12. Bodnar E, Butchart EG, Bamford J, Besselaar AM, Grunkemeier GL, Frater RW. Proposal for reporting thrombosis, embolism and bleeding after heart valve replacement. J Heart Valve Dis 1994;3:120-123
13. Agnihotri AK, McGiffin DC, Galbraith AJ, O'Brien MF. The prevalence of infective endocarditis after aortic valve replacement. J Thorac Cardiovasc Surg 1995;110:1708-1720
14. Calderwood SB, Svvinski LA, Waternaux CM, Karchmer AW, Buckley MJ. Risk factors for the development of prosthetic valve endocarditis. Circulation 1985;72:31-37
15. Chastre J, Trouillet JL. Early infective endocarditis on prosthetic valves. Eur Heart J 1995;16(Suppl. B):32-38
16. Ivert TS, Dismukes WE, Cobbs CG, Blackstone EH, Kirklin JW, Bergdahl LA. Prosthetic valve endocarditis. Circulation 1984;69:223-232
17. Vlessis AA, Khaki A, Grunkemeier GL, Li HH, Starr A. Risk, diagnosis and management of prosthetic valve endocarditis: A review. J Heart Valve Dis 1997;6:443-465
18. Anderson WN, Jr. Spreadsheet method for determining sample sizes for heart valve studies. J Heart Valve Dis 1995;4(1):95-98
19. Walker DK, Scotten LN. A database obtained from in vitro function testing of mechanical heart valves. J Heart Valve Dis 1994;3:561-570
20. Cox DR. Some simple approximate test for Poisson variates. Biometrika 1953;40:354-360
21. Grunkemeier GL, Chandler JG, Miller DC, Jamieson WR, Starr A. Utilization of manufacturers' implant card data to estimate heart valve failure. J Heart Valve Dis 1993;2:493-503
22. Grunkemeier GL, Starr A. Alternatives to randomization in surgical studies. J Heart Valve Dis 1992;1:142-151
23. Sahai, Kurshid A. Confidence intervals for the mean of a Poisson distribution: A review. Biomed J 1993;35:857-867
24. Thomas DR, Grunkemeier GL. Confidence interval estimation of survival probabilities for censored data. J Am Stat Assoc 1975;70:865-871
25. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. John Wiley & Sons, 1980
26. Gross AJ, Clark VA. Survival distributions: Reliability applications in the biomedical sciences. John Wiley & Sons, 1975
27. Blackstone E. Methods and limitations of follow-up assessments of replacement cardiac valves. In: Bodnar E, Frater R (ed). Replacement Cardiac Valves. Pergamon, New York, 1991:Chapter 17
28. Cox DR, Oakes D. Analysis of Survival Data. In: Cox DR, Hinkley DV (ed). Monographs on Statistics and Applied Probability. Chapman & Hall, London, 1984
29. Lawless JF. Statistical models and methods for life-time data. John Wiley & Sons, New York, 1982